Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transfusion policy in ABO-incompatible allogeneic stem cell transplantation.
Worel N, Panzer S, Reesink HW, Linkesch W, Dickmeiss E, Fischer-Nielsen A, Hölig K, Stachel D, Zimmermann R, Holter W, Coluccia P, Brilhante D, Watz E, Sigle JP, Gratwohl A, Buser A, Arslan O, Regan F, Edwards M. Worel N, et al. Among authors: linkesch w. Vox Sang. 2010 Apr;98(3 Pt 2):455-67. doi: 10.1111/j.1423-0410.2009.01292.x. Epub 2010 Jan 8. Vox Sang. 2010. PMID: 20070647 No abstract available.
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation.
Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A, Höcker P, Dieckmann K, Fischer G, Rosenmayr A, Linkesch W, Hinterberger W, Lechner K, Greinix HT. Worel N, et al. Among authors: linkesch w. Bone Marrow Transplant. 2002 Nov;30(9):619-26. doi: 10.1038/sj.bmt.1703677. Bone Marrow Transplant. 2002. PMID: 12407437
Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
Worel N, Rosskopf K, Neumeister P, Kasparu H, Nachbaur D, Russ G, Namberger K, Witt V, Schloegl E, Zojer N, Linkesch W, Kalhs P, Greinix HT. Worel N, et al. Among authors: linkesch w. Transfusion. 2011 May;51(5):968-75. doi: 10.1111/j.1537-2995.2010.02896.x. Epub 2010 Sep 28. Transfusion. 2011. PMID: 20880037 Clinical Trial.
Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma.
Mitterbauer M, Neumeister P, Kalhs P, Brugger S, Fischer G, Dieckmann K, Hoecker P, Hinterberger W, Linkesch W, Simonitsch I, Jaeger U, Lechner K, Mannhalter C, Mitterbauer G, Greinix HT. Mitterbauer M, et al. Among authors: linkesch w. Leukemia. 2001 Apr;15(4):635-41. doi: 10.1038/sj.leu.2402053. Leukemia. 2001. PMID: 11368367
Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.
Greinix HT, Nachbaur D, Krieger O, Eibl M, Knöbl P, Kalhs P, Lutz D, Linkesch W, Niederwieser D, Hinterberger W, Lechner K, Rosenmayr A, Gritsch B. Greinix HT, et al. Among authors: linkesch w. Br J Haematol. 2002 Jun;117(4):914-23. doi: 10.1046/j.1365-2141.2002.03532.x. Br J Haematol. 2002. PMID: 12060131 Free article.
What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small country.
Rosenmayr A, Pointner-Prager M, Mitterschiffthaler A, Bozic L, Pelzmann B, Tüchler H, Fae I, Fischer GF, Greinix HT, Peters Ch, Kalhs P, Krieger O, Linkesch W, Nachbaur D, Urban Ch, Posch U, Lanzer G, Gabriel Ch, Schennach H, Mayr WR. Rosenmayr A, et al. Among authors: linkesch w. Bone Marrow Transplant. 2012 Feb;47(2):172-80. doi: 10.1038/bmt.2011.67. Epub 2011 Apr 4. Bone Marrow Transplant. 2012. PMID: 21460872
Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion.
Keil F, Kalhs P, Haas OA, Fritsch G, Mitterbauer G, Brugger S, Lechner K, Schwarzinger I, Mannhalter C, Linkesch W, Kurz M, Greinix HT. Keil F, et al. Among authors: linkesch w. Br J Haematol. 1996 Jul;94(1):120-2. doi: 10.1046/j.1365-2141.1996.d01-1770.x. Br J Haematol. 1996. PMID: 8757519
224 results